Next Article in Journal
Discovery of N-glycan Biomarkers for the Canine Osteoarthritis
Next Article in Special Issue
Plasma Long Noncoding RNA LeXis is a Potential Diagnostic Marker for Non-Alcoholic Steatohepatitis
Previous Article in Journal
From Bench to Bedside in Tongue Muscle Cancer Invasion and Back again: Gross Anatomy, Microanatomy, Surgical Treatments and Basic Research
Previous Article in Special Issue
Fatty Liver, and Not Visceral Fat, Is More Associated with Liver Fibrosis and Diabetes in Non-Obese Japanese Individuals: A Cross-Sectional Study
Open AccessReview

Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome

1
Division of Gastroenterology and Hepatology, Rutgers New Jersey Medical School, 185 South Orange Avenue, H-532, Newark, NJ 07103, USA
2
Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA
Life 2020, 10(9), 198; https://doi.org/10.3390/life10090198
Received: 24 August 2020 / Revised: 9 September 2020 / Accepted: 11 September 2020 / Published: 13 September 2020
(This article belongs to the Special Issue Fatty Liver Syndrome)
Fatty liver syndrome is an emerging health problem in the world, due to the high prevalence of obesity and alcohol use disorder. Given the nature of the disease’s advancement to cirrhosis and liver-related complications, it is important to assess the severity of the disease, which is typically done via a liver biopsy. Due to the limitations and risks of liver biopsy, the role of noninvasive tests is essential and evolving to stratify the stage of the liver disease, predict the outcomes, and/or monitor the treatment response. This review is focused on noninvasive tests, including the use of serum-based biomarkers, ultrasound-based shear wave elastography, transient elastography, and magnetic resonance elastography in both clinical and research settings. View Full-Text
Keywords: fatty liver syndrome; non-alcoholic fatty liver disease; alcoholic liver disease; hepatic fibrosis; hepatic steatosis fatty liver syndrome; non-alcoholic fatty liver disease; alcoholic liver disease; hepatic fibrosis; hepatic steatosis
Show Figures

Figure 1

MDPI and ACS Style

Han, M.A.T. Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome. Life 2020, 10, 198. https://doi.org/10.3390/life10090198

AMA Style

Han MAT. Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome. Life. 2020; 10(9):198. https://doi.org/10.3390/life10090198

Chicago/Turabian Style

Han, Ma A.T. 2020. "Noninvasive Tests (NITs) for Hepatic Fibrosis in Fatty Liver Syndrome" Life 10, no. 9: 198. https://doi.org/10.3390/life10090198

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop